- Turkish Journal of Internal Medicine
- Vol: 3 Issue: Supplement 1 Special Issue
- A peripartum cardiomyopathy case treated with bromocriptine
A peripartum cardiomyopathy case treated with bromocriptine
Authors : Şeyda Günay, Osman Akın Serdar, Dilek Yeşilbursa, Sümeyye Güllülü, Naile Bolca Topal
Pages : 117-119
Doi:10.46310/tjim.868729
View : 18 | Download : 4
Publication Date : 2021-03-07
Article Type : Other
Abstract :Introduction: Peripartum cardiomyopathy is a rare disease that is difficult to diagnose and treat. Clinical findings are similar with heart failure. New treatments are needed in addition to the treatment of heart failure. Case Report: A 32-year-old woman presented with symptoms of heart failure 4 days after first delivery. Chest X-ray showed cardiomegaly. Serum BNP level was high. Transthoracic echocardiography (TTE) indicated dilated left atrium and left ventricle, severe mitral regurgitation and ventricular dysfunction. The global longitudinal strain was – 9.1%. Cardiac magnetic resonance imaging (MRI) revealed mid-myocardial staining detected in late phase images. Concomitant bromocriptine (2,5 mg po twice a day for 15 days and then 2,5 mg po once a day for 15 days) was used with standard heart failure therapy. At 6 months, TTE and cardiac MRI revealed normal biventricular function and size. Global longitudinal strain was –14%. Conclusion: Patients with peripartum cardiomyopathy may benefit from bromocriptine.Keywords : peripartum, heart, failure, cardiomyoathy, bromocriptine